Twenty-eight Oregon seniors have won one of the most prestigious academic awards for high schoolers, the $2,500 National ...

Me will hold a second auction for its DNA data with an opening bid of $305 million from former CEO Anne Wojcicki. Here's all ...

MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial.

After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...

The sale of genetic testing company 23andMe—which includes genetic data from around 16 million customers—took a new turn at a ...

Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...

Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...

He shared with us his struggle and how his current prosthetic was not really helping him out,” Skotnikov said. “That made us ...